Investing in Disruptive Tech Startups Across America

Congratulations to Mercury Fund portfolio company, Cart.com, on their $18M growth equity round led by Springcoast and with participation from Mercury Fund, Oak HC/FT, and strategic investor PayPal, through its venture investment arm.

“With long-term capital and aligned partners, we believe we can accelerate innovation across our platform, expand our AI capabilities, continue improving automation across our operations, and pursue sustainable profitability as we grow.” – Omair Tariq, CEO and co-founder.

BitGo went public today as the first IPO of 2026, with shares trading on the NYSE under the ticker BTGO.

Since 2013, BitGo has built regulated, institutional-grade digital asset infrastructure spanning custody, wallets, staking, trading, financing, and settlement. This public debut marks a major step for the industry and points to the institutionalization of blockchain and crypto. BitGo acquired Mercury portfolio company Brassica in 2024, expanding its escrow and custodial infrastructure capabilities.

Congratulations to Mike Belshe, CEO and Co-Founder, and the entire team on this milestone.

Mercury portfolio company Plasma, a Bitcoin sidechain focused on stablecoins, has launched its mainnet and native token XPL. At launch, the platform recorded $2B in stablecoin TVL, positioning Plasma among the world’s top 10 blockchains with a fully diluted valuation above $8B. Congratulations to CEO Paul Faecks, CTO Hans Behrens, and the entire team on this milestone.

Congratulations to Ambiq CEO Fumihide Esaka, founder and CTO Scott Hanson and the entire team on their IPO. A pioneer in ultra-low-power semiconductor design, Ambiq’s SPOT® technology enables AI to run locally on devices without draining battery life. From wearables to industrial IoT, Ambiq’s innovation is well-timed as edge computing becomes essential across industries.

Angela Holmes, CEO and Co-Founder of OmniScience, has been named AI Entrepreneur of the Year by Women in AI. Angela was recognized for her visionary leadership in building Vivo, the first agentic AI control tower for clinical trials, driving real-world impact across the life sciences industry. Under her direction, OmniScience is transforming how biotech and pharma teams use AI to accelerate development, reduce delays, and deliver treatments faster.

Congratulations to CEO Sameer Soleja and the Molecule team on their Series B funding, led by Sundance Growth. Molecule’s AI-enabled, SaaS-based ETRM platform is transforming how energy and commodities traders manage complex, multi-commodity portfolios with speed, precision, and scalability. This round will fuel continued innovation, global growth, and Molecule’s mission to deliver the most advanced ETRM platform in the market.